co.don AG
Develops autologous cell therapies for regenerative treatment of cartilage defects.
CNW | F
Overview
Corporate Details
- ISIN(s):
- DE000A3E5C08 (+1 more)
- LEI:
- 3912006R73YW0SX1KG21
- Country:
- Germany
- Address:
- Warthestr. 21, 14513 Teltow
- Website:
- https://www.codon.de/en/
- Sector:
- Manufacturing
Description
co.don AG is a biopharmaceutical company specializing in tissue engineering and regenerative medicine. The company develops, manufactures, and markets autologous cell therapies for the minimally invasive, regenerative treatment of articular cartilage defects. Its core technology involves cultivating a patient's own cartilage cells (chondrocytes) and forming them into three-dimensional spheroids. This product, known as Spherox, is then implanted into the damaged knee cartilage to promote natural tissue regeneration. This personalized therapeutic approach aims to restore joint function and provide a durable, biological solution for cartilage repair.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-09-30 00:00 |
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.01.2022 bis zum 30.0…
|
German | 142.4 KB | ||
| 2022-09-29 00:00 |
Hinweis auf Halbjahresfinanzbericht vom 01.01.2022 bis zum 30.06.2022
|
German | 6.4 KB | ||
| 2022-07-11 00:00 |
Jahres- und Konzernabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021
|
German | 1.3 MB | ||
| 2022-07-06 00:00 |
Berichtigung der Veröffentlichung vom 14.06.2022
|
German | 6.4 KB | ||
| 2022-06-14 00:00 |
Berichtigt am 06.07.2022
|
German | 6.4 KB | ||
| 2022-04-29 00:00 |
Hinweis auf Jahresfinanzbericht vom 01.01.2021 bis zum 31.12.2021
|
German | 6.4 KB | ||
| 2021-09-11 00:00 |
CO.DON AG: Mitteilung über Eigengeschäfte von Führungskräften gem. Art. 19 MAR
|
German | 13.9 KB | ||
| 2021-08-30 00:00 |
Halbjahresfinanzbericht
|
German | 148.6 KB | ||
| 2021-05-27 00:00 |
Jahresabschluss zum Geschäftsjahr vom 01.01.2020 bis zum 31.12.2020
|
German | 4.2 KB | ||
| 2021-05-25 00:00 |
Konzernabschluss zum Geschäftsjahr vom 01.01.2020 bis zum 31.12.2020
|
German | 4.2 KB | ||
| 2021-05-22 00:00 |
Ad-hoc-Meldung gemäß Art. 17 MAR in Verbindung mit § 4 Abs. 1 S. 1 Nr. 1a WpAV
|
English | 11.8 KB | ||
| 2020-08-28 00:00 |
Datum:28.08.2020
|
German | 381.2 KB | ||
| 2020-08-24 00:00 |
Datum:24.08.2020
|
German | 12.2 KB | ||
| 2020-07-28 00:00 |
Datum:28.07.2020
|
German | 998.8 KB | ||
| 2020-07-07 00:00 |
Datum:07.07.2020
|
German | 41.3 KB |
Automate Your Workflow. Get a real-time feed of all co.don AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for co.don AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for co.don AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2021-10-21 | Günther, Bernd | Supervisory board | Buy | None | 35.84 EUR |
| 2021-10-20 | Laik, Robin | Board | Other | None | 10,348,300.00 EUR |
| 2021-10-20 | ELBER GmbH | Close relation | Other | None | 10,179,000.00 EUR |
| 2021-10-20 | Rofalski, Volker | Supervisory board | Other | None | 292,500.00 EUR |
| 2021-10-20 | Müller, Dr. Axel | Supervisory board | Other | None | 195,000.00 EUR |
| 2021-10-20 | Laumann, Johannes | Board | Other | None | 131,625.00 EUR |
| 2021-10-20 | Laik, Louisa | Close relation | Other | None | 129,987.00 EUR |
| 2021-10-20 | Laik, Daniel | Close relation | Other | None | 97,500.00 EUR |
| 2021-10-20 | Friedrich, Neela | Close relation | Other | None | 64,993.50 EUR |
| 2021-10-20 | Schleede, Dr. Kristian | Board | Other | None | 29,250.00 EUR |
Peer Companies
